AQS — Aequus Pharmaceuticals Cashflow Statement
0.000.00%
Last trade - 00:00- CA$0.66m
- CA$7.23m
- CA$0.58m
Annual cashflow statement for Aequus Pharmaceuticals, fiscal year end - December 31st, CAD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -1.05 | -1.81 | -3.21 | -2.96 | -2.18 |
| Depreciation | |||||
| Amortisation | |||||
| Non-Cash Items | 0.551 | 0.48 | 0.682 | 0.117 | 0.074 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -0.522 | 0.029 | 0.446 | 0.415 | 0.315 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Prepaid Expenses | |||||
| Change in Payable / Accrued Expenses | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | -0.805 | -1.17 | -1.95 | -2.29 | -1.66 |
| Capital Expenditures | -0.012 | -0.004 | 0 | — | — |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | — | -0.504 | 0 | — | 0.045 |
| Sale/Maturity of Investment | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -0.012 | -0.508 | 0 | — | 0.045 |
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 2.05 | 2.4 | -0.189 | 2.21 | 1.49 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 1.23 | 0.718 | -2.14 | -0.08 | -0.12 |